In general, three different groups of agents were described in the past: (i) mAbs, either targeting the ligand HGF or the receptor Met, (ii) tyrosine kinase inhibitors, targeting the tyrosine kinase domain of Met (and mostly also the TK domain of other RTKs), (iii) a truncated, soluble Met receptor serving as decoy for HGF (44) and the competitive HGF antagonist NK4 (18)
It is not an instruction for use
Everything was as described and met my expectations
Although ROS, along with various factors in spermatozoa, increase the production of intracellular cAMP, which activates protein Kinase A (PKA), thereby inducing an increase in tyrosine phosphorylation, the main driving force behind sperm hypermotility and subsequent acrosome reaction [32], mature spermatozoa and the different stages of spermatogenesis are particularly susceptible to damage caused by ROS [33]
and others, whose experiments also revealed increased activity of Sox9 and aggrecan when stimulated by PRP